Skip to main content

Media Category: Management

Long-term Efficacy and Safety of Anti-CD20 Therapies

Anti-CD20 therapies have transformed the treatment landscape of Multiple Sclerosis (MS), offering highly effective disease control through targeted B-cell depletion. As these therapies are increasingly used early in the disease course and maintained over many years, understanding their long-term efficacy, safety, and optimal use has become essential for clinical practice. In this webinar, Celia Oreja-Guevara and Patrick Vermersch review the latest evidence on anti-CD20 therapies, including ocrelizumab, ofatumumab, rituximab, and ublituximab. Drawing from pivotal clinical trials, extension...

Continue reading

NMOSD Panel Discussion: Pathophysiology, Monitoring, and Treatment Challenges

This expert panel discussion explores the current challenges in understanding and managing neuromyelitis optica spectrum disorder (NMOSD). Bringing together clinical perspectives, the conversation highlights gaps in pathophysiology, limitations in monitoring tools, and ongoing uncertainties in long-term treatment strategies. Despite advances in biomarkers and therapies, real-world decision-making remains largely driven by clinical experience. Key Insights from the Lecture: Antibodies alone are not sufficient to cause disease Clinical context remains essential T cells play a...

Continue reading

Multiple Sclerosis and pregnancy: from planning to postpartum

Family planning is a central concern for women living with multiple sclerosis, as the disease often affects patients during their reproductive years. Questions around pregnancy, treatment safety, and postpartum relapse risk require careful, individualized planning. With the right multidisciplinary approach and treatment strategies, pregnancy can be safely managed while minimizing risks for both mother and child. Key Insights from the Lecture: Family planning is a key concern in MS care Pregnancies are not always planned Planning pregnancy reduces risks Multidisciplinary...

Continue reading

Jelena Drulović on the power of interactive education in advancing MS care

In this short interview, Jelena Drulović reflects on the value of interactive, discussion-based education in multiple sclerosis care. Watch the interview Why is interactive, discussion-based education essential for improving multiple sclerosis care? Jelena Drulović explains how active engagement between experts and clinicians enhances knowledge transfer and translates scientific discussion into better clinical practice. Key points discussed include: Why interactive, discussion-based education strengthens MS care The value of direct exchange between experts and practicing...

Continue reading

Independent Education in the Age of the Internet and AI – Celia Oreja-Guevara, President of ParadigMS

In this short video interview, Celia Oreja-Guevara reflects on the challenges facing the new generation of neurologists. In a time when information is instantly accessible online and artificial intelligence is increasingly used, she emphasises the importance of independent medical education and critical thinking. Watch the interview Why is independent medical education especially important in the age of AI and online information? Celia Oreja-Guevara highlights that while today’s generation has rapid access to information, true medical learning requires more than searching online....

Continue reading

Looking Ahead: A Shared European Vision for ParadigMS

In this short video interview, Celia Oreja-Guevara, ParadigMS President, shares her vision for the next five years of ParadigMS. Celia outlines an ambition to develop collaborative scientific projects and strengthen the foundation’s presence within the European neurological community. Watch the interview Celia highlights: The ambition to develop a joint European scientific project Strengthening collaboration across countries and specialisations Moving beyond review articles toward more dissemination of original research Publishing work that reflects real clinical practice...

Continue reading

  • 1
  • 2

FAQs

Is ParadigMS for free?

Yes, a ParadigMS subscription is free for healthcare practitioniers. 

Do subscriptions auto-renew?
Your subscription will automatically renew on yearly basis. If you cancel your plan, it will not renew at the end of your subscription cycle. 
I am a representative from industry, can I subscribe?

Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material. 

What happens if I subscribe as a HCP if I am not?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately. 
I am a patient, can I subscribe?

ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.

Why should I subscribe to ParadigMS's e-platform?

Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.

How can I cancel my subscription?
You can cancel your subscription in your account settings. 
Can I financially support ParadigMS?

Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.